Search Results - Nigel Russell
- Showing 1 - 18 results of 18
-
1
-
2
-
3
-
4
A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin’s lymphoma receiving chemotherapy by Nigel Russell, Rolf Mesters, Joerg Schubert, Marc Boogaerts, Hans E. Johnsen, Consuelo del Canizo, Nigel Baker, Philippa Barker, Tomas Skacel, Norbert Schmitz
Published in Haematologica (2008-03-01)Get full text
Article -
5
Relationship between event-free survival and overall survival in acute myeloid leukemia: a report from SWOG, HOVON/SAKK, and MRC/NCRI by Megan Othus, Wim van Putten, Bob Lowenberg, Stephen H. Petersdorf, Sucha Nand, Harry Erba, Frederick Appelbaum, Robert Hills, Nigel Russell, Alan Burnett, Elihu Estey
Published in Haematologica (2016-07-01)Get full text
Article -
6
P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS by Pramila Krishnamurthy, Myrsini Gianatsi, Sophie Wintrich, Abin Thomas, Lynn Quek, Austin Kulasekararaj, Priyanka Mehta, Sreetharan Munisamy, Nigel Russell, Mike Dennis, Elspeth Payne, Ian Thomas
Published in HemaSphere (2023-08-01)Get full text
Article -
7
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure by Emma Das-Gupta, Hildegard Greinix, Ryan Jacobs, Li Zhou, Bipin N. Savani, Brian G. Engelhardt, Adetola Kassim, Nina Worel, Robert Knobler, Nigel Russell, Madan Jagasia
Published in Haematologica (2014-11-01)Get full text
Article -
8
S131: A RANDOMISED ASSESSMENT OF THE SEQUENTIAL ADDITION OF THE KINASE INHIBITOR QUIZARTINIB TO INTENSIVE CHEMOTHERAPY IN OLDER ACUTE MYELOID LEUKAEMIA (AML) PATIENTS: RESULTS FROM... by Steven Knapper, Abin Thomas, Sophie King, Ian Thomas, Amanda Gilkes, Sarah Irwin, Robert Sellar, Simone Green, Ulrik Malthe Overgaard, Priyanka Mehta, Mike Dennis, Sylvie Freeman, Nigel Russell
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Defining the dose of gemtuzumab ozogamicin in combination with induction chemotherapy in acute myeloid leukemia: a comparison of 3 mg/m2 with 6 mg/m2 in the NCRI AML17 Trial by Alan Burnett, Jamie Cavenagh, Nigel Russell, Robert Hills, Jonathan Kell, Gail Jones, Ove Juul Nielsen, Asim Khwaja, Ian Thomas, Richard Clark, on behalf of the UK NCRI AML Study Group
Published in Haematologica (2016-06-01)Get full text
Article -
10
Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the... by Nigel Russell, Kenny Douglas, Anthony D. Ho, Mohamad Mohty, Kristina Carlson, G.J. Ossenkoppele, Giuseppe Milone, Macarena Ortiz Pareja, Daniel Shaheen, Arnold Willemsen, Nicky Whitaker, Christian Chabannon
Published in Haematologica (2013-02-01)Get full text
Article -
11
S136: ANALYSIS OF FACTORS ASSOCIATED WITH LONG-TERM SURVIVAL IN A LARGE ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENT COHORT: A HARMONY ALLIANCE STUDY by Luca Guarnera, Soren Lehmann, Konstanze Döhner, Hartmut Döhner, Gert Ossenkoppele, Nigel Russell, Richard Dillon, Uwe Platzbecker, Marco Vignetti, Edoardo la Sala, Angela Villaverde, Laura Tur, Jesus Hernández Rivas, Maria Teresa Voso
Published in HemaSphere (2023-08-01)Get full text
Article -
12
P484: GEMTUZUMAB-BASED INDUCTION CHEMOTHERAPY COMBINED WITH MIDOSTAURIN FOR FLT3 MUTATED AML. UPDATED TOXICITY AND INTERIM SURVIVAL ANALYSIS FROM THE NCRI AML19V2 “MIDOTARG” PILOT... by Nigel Russell, Oliver Cumming, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Jelena Jovanovic, Amanda Gilkes, Leona Batten, Joanna Canham, Emily Laura Hinson, Panagiotis Kottaridis, Jamie Cavenagh, Claire Arnold, Mike Dennis, Steven Knapper
Published in HemaSphere (2023-08-01)Get full text
Article -
13
S134: FLAG-IDA COMBINED WITH GEMTUZUMAB OZOGAMICIN (GO) REDUCED MRD LEVELS AND IMPROVED OVERALL SURVIVAL IN NPM1MUT AML INDEPENDENT OF FLT3 AND MRD STATUS, RESULTS FROM THE AML19 T... by Nigel Russell, Jad Othman, Richard Dillon, Nicola Potter, Charlotte Wilhelm-Benartzi, Steven Knapper, Leona Batten, Joanna Canham, Emily Laura Hinson, Ulrik Malthe Overgaard, Amanda Gilkes, Priyanka Mehta, Panagiotis Kottaridis, Jamie Cavenagh, Claire Hemmaway, Claire Arnold, Sylvie Freeman, Mike Dennis
Published in HemaSphere (2023-08-01)Get full text
Article -
14
Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin’s lymphoma: identification of prognostic factors predicting outcome by Stephen P. Robinson, Anna Sureda, Carmen Canals, Nigel Russell, Dolores Caballero, Andrea Bacigalupo, Arturo Iriondo, Gordon Cook, Andrew Pettitt, Gerard Socie, Francesca Bonifazi, Alberto Bosi, Mauricette Michallet, Effie Liakopoulou, Johan Maertens, Jakob Passweg, Fiona Clarke, Rodrigo Martino, Norbert Schmitz
Published in Haematologica (2009-02-01)Get full text
Article -
15
P503: A RANDOMISED TRIAL OF MOLECULAR MONITORING VERSUS STANDARD CLINICAL CARE IN YOUNGER ADULTS WITH ACUTE MYELOID LEUKAEMIA: RESULTS FROM THE UK NCRI AML17 AND AML19 STUDIES by Nicola Potter, Jelena Jovanovic, Adam Ivey, Abin Thomas, Charlotte Wilhelm-Benartzi, Amanda Gilkes, Ian Thomas, Sean Johnson, Joanna Canham, Steven Knapper, Asim Khwaja, Mary Frances Mcmullin, Jamie Cavenagh, Ulrik Malthe Overgaard, Richard Clark, Ellen Solomon, Sylvie Freeman, Robert Hills, Alan Burnett, Nigel Russell, Richard Dillon
Published in HemaSphere (2023-08-01)Get full text
Article -
16
Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia by Charles Craddock, Sandeep Nagra, Andrew Peniket, Cassandra Brookes, Laura Buckley, Emmanouil Nikolousis, Nick Duncan, Sudhir Tauro, John Yin, Effie Liakopoulou, Panos Kottaridis, John Snowden, Donald Milligan, Gordon Cook, Eleni Tholouli, Tim Littlewood, Karl Peggs, Paresh Vyas, Fiona Clark, Mark Cook, Stephen MacKinnon, Nigel Russell
Published in Haematologica (2010-06-01)Get full text
Article -
17
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorde... by Mohamad Sobh, Mauricette Michallet, Valérie Dubois, Simona Iacobelli, Linda Koster, Anja Van Biezen, Nathalie Fegueux, Reza Tabrizi, Jürgen Finke, Jean El-Cheikh, Martin Schipperus, Ellen Meijer, Peter von dem Borne, Eefke Petersen, Nigel Russell, Eleni Tholouli, Jakob Passweg, Frédéric Garban, Johan Maertens, Patrice Chevalier, Natacha Maillard, Liisa Volin, Sylvie Francois, Bruno Lioure, Yves Beguin, Eliane Gluckman, Annalisa Ruggeri, Laurent Garderet, Nicolaus Kröger
Published in Haematologica (2017-07-01)Get full text
Article -
18
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet by Adriano Venditti, Raffaele Palmieri, Luca Maurillo, Christoph Röllig, Agnieszka Wierzbowska, David de Leeuw, Fabio Efficace, Antonio Curti, Lok Lam Ngai, Jesse Tettero, Lionel Adès, Antonio Almeida, Lars Bullinger, Mike Dennis, Jordi Esteve, Felicetto Ferrara, Michael Heuser, Gerwin Huls, Michael Lübbert, Priyanka Mehta, Pau Montesinos, Thomas Pabst, Christian Récher, Giuseppe Rossi, Nigel Russell, Jorge Sierra, Reinhard Stauder, Norbert Vey, Roland B. Walter, Eunice Wang, Samantha Nier, Carolina Garcez Martins, Gert Ossenkoppele
Published in Blood Advances (2025-05-01)Get full text
Article
